Norman L. Sussman's most recent trade in Durect Corp was a trade of 46,425 Common Stock done . Disclosure was reported to the exchange on July 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Durect Corp | Norman L. Sussman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 46,425 | 46,425 (0%) | 0% | 0 | Common Stock | |
| Durect Corp | L. Sussman Norman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2024 | 104,000 | 104,000 | - | - | Stock Option (right to buy) | |
| Durect Corp | Norman L. Sussman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Durect Corp | Norman L. Sussman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 24,557 | 24,557 | - | - | Stock Option (right to buy) | |
| Durect Corp | Norman L. Sussman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 398,380 | 398,380 | - | - | Stock Option (right to buy) | |
| Durect Corp | Norman L. Sussman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 10 Dec 2021 | 9,000 | 0 (0%) | 0% | 1.1 | 9,495 | Common Stock |
| Durect Corp | Norman L. Sussman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Durect Corp | Norman L. Sussman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 200,000 | 200,000 | - | - | Stock Option |